Objectives To evaluate the in vitro activity of the combination of apramycin with colistin,
meropenem, minocycline or sulbactam, against some well-characterized XDR Acinetobacter …

Extensively drug-resistant (XDR) Acinetobacter spp. have emerged as a cause of
nosocomial infections, especially under conditions of intensive care. Unfortunately …

Background: Extensively drug resistant Acinetobacter baumannii (XDR-AB) presents an
increasing challenge to health care in Egypt as they are among the most common bacteria …

Carbapenem-resistant Acinetobacter baumannii (CR-Ab) infections are associated with high
morbidity and mortality. The aim of the study was to evaluate the in-vitro activity of different …

Georgios Meletis E-mail: meletisg@ hotmail. com© 2022 by EDIMES-Edizioni Internazionali
Srl. All rights reserved sents increased activity as well as resistance to tetracycline-specific …

Abstract Background The Gastrointestinal Surgery Center (GISC)—Mansoura University,
faced a series of extensive drug resistant (XDR) A. baumannii cases, that were …

Treatment options for multidrug-resistant (MDR) and extensively drug-resistant (XDR)
Acinetobacter baumannii have been seriously limited and may require combination …

Acinetobacter baumannii remains a difficult-to-treat pathogen that poses a significant
challenge to clinicians and costs to the healthcare system. There is a lack of clinical efficacy …

The existence of infections caused by multidrug resistant (MDR) Acinetobacter baumannii is
a growing problem because of the difficulty to treat them. We examined the published …

Apramycin, an aminocyclitol aminoglycoside, was rapidly bactericidal against Acinetobacter
baumannii. In a neutropenic murine thigh infection model, treatment-associated A …